FIELD MAP / TUMOR TYPE

Gastric cancer

Gastric / stomach cancer — explored for neoantigen vaccines plus immunotherapy.

Topic2 items2026-06-03 – 2026-06-15

Tumor types

Glioblastoma25 Melanoma23 Pancreatic cancer19 Colorectal cancer18 Lung cancer (NSCLC)17 Breast cancer11 Liver cancer (HCC)8 Kidney cancer (RCC)7 Lynch syndrome7 Head & neck cancer5 Ovarian cancer2 Gastric cancer2 Prostate cancer2 Bladder cancer1

Clinical

Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer

XH001, a neoantigen vaccine, is being tested in Phase I for advanced gastric cancer. The Jia Wei-led study evaluates the safety and efficacy of combining XH001 with neoantigen-induced tumor-specific T-cell injections to determine if the regimen can shrink tumors or prolong survival.

clinicaltrials · brief 2026-06-15 · published 2026-02-25

Clinical

Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer

Jia Wei is leading a Phase I trial assessing the safety and preliminary efficacy of XH001 injection combined with neoantigen vaccine-induced tumor-specific T-cell injection in advanced gastric cancer. The study aims to determine if this combined cellular and vaccine approach can shrink tumors and prolong survival in adult patients.

clinicaltrials · brief 2026-06-03 · published 2026-02-25